Nexstim Targets US Stroke Rehab Market With MRI-Guided Transcranial Magnetic Stimulation

Noninvasive Navigated Brain Therapy system is undergoing a pivotal study in the US to improve brain function following a stroke.

Finnish noninvasive brain stimulation company Nexstim PLC is eyeing the US as the first launch market for its Navigated Brain Therapy system for post-acute stroke treatment once it completes an ongoing pivotal trial.

Nexstim CEO Janne Huhtala says in an interview that the US stroke rehabilitation centers offer a unique marketing opportunity because “right now, nobody else is selling anything to these guys, and that's what

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation

Faster Device Certification Among Keys To Unlocking Innovation In EU MedTech Sector

 

While MedTech Europe sharpens its focus on what the EU most urgently needs to advance the medtech market in four targeted measures, the European Commission has also unveiled four priorities for 2025.

Beyond The Bladder: Incontinence Impacts Mental Health

 

In recognition of Mental Health Awareness month, Sarah Jenkins, executive director at the National Association for Continence, discussed the mental health issues that often come with incontinence.

AI Rollout Aims To Accelerate FDA’s Product Review Process

 
• By 

The FDA plans to implement artificial intelligence in its scientific review process by 30 June, following a successful pilot. The agency hopes the tool will reduce nonproductive tasks for reviewers amid recent staff cuts. A Chief AI Officer will oversee the rollout and integration.